43 - OPAT in People who Inject Drugs

Speaker(s)

• TF

  Thomas Fraser, MD

  Staff
  Infectious disease
  Cleveland Clinic Foundation
  Cleveland, Ohio

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Monica Mahoney, PharmD, BCPS-AQ ID, BCIDP

  Clinical Pharmacy Specialist, Ambulatory/Infectious Diseases
  Beth Israel Deaconess Medical Center
  Boston, Massachusetts

  Disclosure: Cepheid : Speakers' bureau (Status: Ongoing); Spero : Advisor or Review Panel member (Status: Ongoing); TetraPhase : Advisor or Review Panel member (Status: Ongoing)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-20-460-H01-P

Learning Objectives:

• identify factors that predict safe and effective use of OPAT in people who inject drugs
• discuss risks and benefits of including OPAT in treatment of infections in people who inject drugs
• describe best practices for administering OPAT to people who inject drugs

Presentations:

• 10:00am – 11:15am EDT

  OPAT in Injection Drug Users - Speaker 1
  Thomas G. Fraser, MD – Cleveland Clinic Foundation
• 10:00am – 11:15am EDT

  OPAT in PWID: The What and the How
  Monica V. Mahoney, PharmD, BCPS-AQ ID, BCIDP – Beth Israel Deaconess Medical Center